Integral Diagnostics Limited (ASX: IDX)

Market Cap	701.75M
Revenue (ttm)	469.70M
Net Income (ttm)	-60.70M
Shares Out	233.92M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	27.82
Dividend	0.06 (1.93%)
Ex-Dividend Date	Aug 30, 2024

Volume	1,992,283
Open	2.920
Previous Close	2.900
Day's Range	2.900 - 3.000
52-Week Range	1.800 - 3.200
Beta	0.73
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 25, 2025

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides positron emission tomography, magnetic resonance imaging, and other radiology services. The company was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 1,977
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX